Literature DB >> 30474261

Prevalence, clinical characteristics and prognosis of EBV-positive follicular lymphoma.

Nicholas Mackrides1, Jennifer Chapman1, Melissa C Larson2, Juan C Ramos3, Ngoc Toomey3, Pei Lin4, Matthew J Maurer2, Myra Rafaelle1, Yaohong Tan1, Offiong Ikpatt1, Sergei Syrbu5, Stephen M Ansell6, Thomas M Habermann6, Brian K Link7, Andrew L Feldman8, Izidore S Lossos3, James R Cerhan6, Francisco Vega1,3.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 30474261      PMCID： PMC6374505          DOI： 10.1002/ajh.25357

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  5 in total

1.  Epstein-Barr virus-positive follicular lymphoma.

Authors:  Nicholas Mackrides; German Campuzano-Zuluaga; Yvan Maque-Acosta; Adrienne Moul; Nouf Hijazi; Francis Offiong Ikpatt; Ronald Levy; Ramiro E Verdun; Kranthi Kunkalla; Yasodha Natkunam; Izidore S Lossos; Francisco Vega; Jennifer Chapman
Journal:  Mod Pathol       Date:  2016-12-16       Impact factor: 7.842

2.  Early event status informs subsequent outcome in newly diagnosed follicular lymphoma.

Authors:  Matthew J Maurer; Emmanuel Bachy; Hervé Ghesquières; Stephen M Ansell; Grzegorz S Nowakowski; Carrie A Thompson; David J Inwards; Cristine Allmer; Catherine Chassagne-Clément; Emmanuelle Nicolas-Virelizier; Catherine Sebban; Laure Lebras; Clementine Sarkozy; William R Macon; Andrew L Feldman; Sergei I Syrbu; Alexandra Traverse-Glehan; Bertrand Coiffier; Susan L Slager; George J Weiner; Thomas E Witzig; Thomas M Habermann; Gilles Salles; James R Cerhan; Brian K Link
Journal:  Am J Hematol       Date:  2016-09-03       Impact factor: 10.047

Review 3.  Epstein-Barr virus: more than 50 years old and still providing surprises.

Authors:  Lawrence S Young; Lee Fah Yap; Paul G Murray
Journal:  Nat Rev Cancer       Date:  2016-09-30       Impact factor: 60.716

4.  Epstein-Barr virus latent membrane protein 1 increases genomic instability through Egr-1-mediated up-regulation of activation-induced cytidine deaminase in B-cell lymphoma.

Authors:  Joo Hyun Kim; Won Seog Kim; Chaehwa Park
Journal:  Leuk Lymphoma       Date:  2013-02-28

Review 5.  EBV-Positive Lymphoproliferations of B- T- and NK-Cell Derivation in Non-Immunocompromised Hosts.

Authors:  Stefan D Dojcinov; Falko Fend; Leticia Quintanilla-Martinez
Journal:  Pathogens       Date:  2018-03-07
  5 in total
  4 in total

Review 1.  Role of Epstein-Barr virus in transformation of follicular lymphoma to diffuse large B-cell lymphoma: a case report and review of the literature.

Authors:  Massimo Granai; Maria Raffaella Ambrosio; Ayse Akarca; Lucia Mundo; Federica Vergoni; Raffaella Santi; Virginia Mancini; Gioia di Stefano; Teresa Amato; Cristiana Bellan; Benedetta Puccini; Ester Sorrentino; Kikkeri N Naresh; Lorenzo Leoncini; Teresa Marafioti; Stefano Lazzi
Journal:  Haematologica       Date:  2019-03-07       Impact factor: 9.941

Review 2.  Evolving insights into the genomic complexity and immune landscape of diffuse large B-cell lymphoma: opportunities for novel biomarkers.

Authors:  Siba El Hussein; Kenna R M Shaw; Francisco Vega
Journal:  Mod Pathol       Date:  2020-07-03       Impact factor: 7.842

3.  Quantitative Off-Target Detection of Epstein-Barr Virus-Derived DNA in Routine Molecular Profiling of Hematopoietic Neoplasms by Panel-Based Hybrid-Capture Next-Generation Sequencing.

Authors:  Kseniya Petrova-Drus; Andrés E Quesada; Anita S Bowman; Ryan Ptashkin; Jinjuan Yao; Maria E Arcila; Caleb Ho; Christine Moung; Jennifer Regalado; Ryma Benayed; Jamal K Benhamida; Pallavi K Galera; Ahmet Dogan; Chad Vanderbilt
Journal:  J Mol Diagn       Date:  2021-11-18       Impact factor: 5.568

4.  Identification and validation of an immunological microenvironment signature and prediction model for epstein-barr virus positive lymphoma: Implications for immunotherapy.

Authors:  Chenjiao Yao; Ruoyao Xu; Qianyuan Li; Sheng Xiao; Min Hu; Linyong Xu; Quan Zhuang
Journal:  Front Oncol       Date:  2022-09-29       Impact factor: 5.738
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.